Ono Pharmaceutical Co. Ltd: all 157 studies

Page 2 of 2. Open to participants first (25), then studies with results posted, then the rest; newest registration first within each.

• A Study of DCC-2701 in Participants With Advanced Solid TumorsTerminatedNCT02228811Phase 1
• A 28 Day Study of ONO-9054 Ophthalmic Solution in Subjects With Ocular Hypertension (OHT) or Open-angle Glaucoma (OAG)CompletedNCT02083289Phase 2
• A Human Mass Balance Study to Determine the Total Recovery of Radioactivity in Urine and Faeces Following a Single Oral Dose of 14C Radiolabelled ONO-4053CompletedNCT01909986Phase 1
• Study to Evaluate the Effects of ONO-2952 on Pain Perception Produced by Rectal Distention in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)TerminatedNCT01887002Phase 2
• A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)CompletedNCT01844180Phase 2
• An Open-label, Single-dose, Intravenous Administration Study of ONO-2745/CNS 7056 in Subjects With Chronic Hepatic ImpairmentCompletedNCT01790607Phase 1
• Phase II Study Evaluating ONO-4053 and Cetirizine in Subjects With Seasonal Allergic RhinitisCompletedNCT01748344Phase 2
• A Study of the Effect of ONO-8539 on Oesophageal Pain Hypersensitivity in Patients With Non-erosive Reflux DiseaseCompletedNCT01707901Phase 1
• A Study to Investigate the Effect of ONO-8539 on Acid-Induced Oesophageal Hypersensitivity in Healthy VolunteersCompletedNCT01705275Phase 1
• Single and Multiple Dose Escalation and Two-sequence Crossover Study of ONO-9054 in Patients With Ocular Hypertension or Mild Open-angle GlaucomaCompletedNCT01670266Phase 1
• ONO-2952 Single-dose PET Study in Healthy Adult SubjectsCompletedNCT01613703Phase 1
• A Placebo and Active Controlled Study of ONO-6950 Following Allergen Challenge in Patients With AsthmaCompletedNCT01551147Phase 2
• A Phase I Study to Evaluate Safety, Tolerability and Pharmacokinetics of ONO-4053 in Healthy VolunteersCompletedNCT01537172Phase 1
• A Placebo and Active Controlled Study of ONO-6950 in Asthmatic PatientsCompletedNCT01536041Phase 2
• MK-0431/ONO-5435 Phase III Clinical Trial-Rapid-acting Insulin Secretagogue Add-on Study in Patients With Type 2 DiabetesCompletedNCT01517321Phase 3
• Single Dose Escalation Study of ONO-9054 in Healthy VolunteersCompletedNCT01508988Phase 1
• Multiple-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ONO-2952 in Healthy Adult SubjectsCompletedNCT01489345Phase 1
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ONO-6950 in Healthy Adult SubjectsCompletedNCT01405651Phase 1
• A Study to Investigate the Effects of Food and Morning Versus Evening on Single and Multiple Doses of ONO-5334 in Healthy Post Menopausal WomenCompletedNCT01384188Phase 1/2
• A Phase I Study to Evaluate Safety, Tolerability and Pharmacokinetics of ONO-4053 in Healthy VolunteersTerminatedNCT01379586Phase 1
• Single-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ONO-2952 in Healthy Adult SubjectsCompletedNCT01364441Phase 1
• A Study of the Safety and Efficacy of ONO-7746 in Adult Cancer Patients With Chemotherapy Induced ThrombocytopeniaTerminatedNCT01345214Phase 1
• Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ONO-6950 in Healthy Adult SubjectsCompletedNCT01297582Phase 1
• ONO-7746 Study in Healthy Adult SubjectCompletedNCT01106664Phase 1
• A Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple SclerosisCompletedNCT01081782Phase 2
• ONO-7746 Study in Healthy Adult SubjectsCompletedNCT00956371Phase 1
• Study of ONO-1101 in Patients Scheduled for Multi-Slice Computed Tomography (CT)CompletedNCT00924586Phase 3
• Study of ONO-8539 in Patients With Overactive BladderCompletedNCT00876421Phase 2
• MK-0431/ONO-5435 Phase III Clinical Trial - Insulin Add-on Study for Patients With Type 2 Diabetes MellitusCompletedNCT00854035Phase 3
• Study Safety and Preliminary Efficacy of DCC-2036 in Patients With Leukemias (Ph+ CML With T315I Mutation)CompletedNCT00827138Phase 1
• A Phase II Multi-centre, Extension Study to Investigate the Long Term Safety of ONO-2506PO in Patients Diagnosed With Amyotrophic Lateral Sclerosis (ALS)CompletedNCT00694941Phase 2
• Study of ONO-1101 in Patients Scheduled for Coronary AngiographyCompletedNCT00560209Phase 2
• Controlled Study of ONO-5334 in Postmenopausal Women With Osteopenia or OsteoporosisCompletedNCT00532337Phase 2
• Placebo-Controlled Study of ONO-2333Ms in Patients With Recurrent Major Depressive DisorderCompletedNCT00514865Phase 2
• Long-term Safety and Efficacy of Imidafenacin in Patients With Overactive BladderCompletedNCT00512785Phase 3
• Controlled Study of ONO-5046Na in Patients With Acute Respiratory Failure Associated With Community-Acquired PneumoniaCompletedNCT00417326Phase 2
• Study of ONO-1078 in Patients With Chronic SinusitisCompletedNCT00410735Phase 3
• Placebo Controlled Study of ONO2506PO in the Presence of Riluzole in Patients With Amyotrophic Lateral Sclerosis (ALS)CompletedNCT00403104Phase 2
• Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes MellitusCompletedNCT00363948Phase 3
• Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes MellitusCompletedNCT00363844Phase 3
• Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes MellitusCompletedNCT00363519Phase 3
• Pilot Study of ONO-5129 in Patients With Type 2 Diabetes MellitusCompletedNCT00335712Phase 2
• Pilot Study of ONO-1101 in Patients Scheduled for Multi-slice CTCompletedNCT00311038Phase 2
• Study of ONO-2506 in Patients With Acute Ischemic StrokeCompletedNCT00229177Phase 2/3
• Study of Sivelestat Sodium Hydrate in Acute Lung Injury (ALI) Associated With Systemic Inflammatory Response Syndrome (SIRS) in JapanCompletedNCT00219375Phase 4
• Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in JapanCompletedNCT00212732Phase 3
• Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in JapanCompletedNCT00212719Phase 3
• Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in JapanCompletedNCT00212706Phase 2
• Controlled Study of ONO-2506PO in Patients With Parkinson's Disease in JapanCompletedNCT00212693Phase 2
• Controlled Study of ONO-1101 in Patients With Postoperative Tachyarrhythmias in JapanCompletedNCT00212680Phase 2
• Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in JapanCompletedNCT00212667Phase 3
• Controlled Study of ONO-1101 in Patients With Postoperative Tachyarrhythmias in JapanCompletedNCT00212654Phase 2/3
• A Phase II Study to Evaluate the Effects of Oral ONO-5129 in Type 2 Diabetes MellitusCompletedNCT00212641Phase 2
• Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in JapanCompletedNCT00212628Phase 3
• ONO-7436 Phase II Study in JapanCompletedNCT00212602Phase 2
• Effects of ONO-2506PO in Patients With Alzheimer's DiseaseCompletedNCT00083421Phase 2
• A Study to Evaluate the Effects of ONO-2506 Intravenous Infusion in Patients With Acute Ischemic StrokeTerminatedNCT00046761Phase 2/3

← Ono Pharmaceutical Co. Ltd overview and focus areas